The Experts below are selected from a list of 693 Experts worldwide ranked by ideXlab platform
Craig Maartmannmoe - One of the best experts on this subject based on the ideXlab platform.
-
iontophoretic administration of Dexamethasone Sodium Phosphate for acute epicondylitis a randomized double blinded placebo controlled study
American Journal of Sports Medicine, 2003Co-Authors: Robert P. Nirschl, Dennis Rodin, Derek Ochiai, Craig MaartmannmoeAbstract:Background: A better treatment modality is needed to control the pain of medial or lateral epicondylitis (tennis elbow).Hypothesis: Dermal iontophoretic administration of Dexamethasone Sodium Phosphate will be significantly more effective in controlling pain than a placebo in patients with medial or lateral elbow epicondylitis.Study Design: Randomized, double-blinded, placebo-controlled study.Methods: On six occasions, 1 to 3 days apart within 15 days, 199 patients with elbow epicondylitis received 40 mA-minutes of either active or placebo treatment.Results: Dexamethasone produced a significant 23-mm improvement on the 100-mm patient visual analog scale ratings, compared with 14 mm for placebo at 2 days and 24 mm compared with 19 mm at 1 month. More patients treated with Dexamethasone than those treated with placebo scored moderate or better on the investigator's global improvement scale (52% versus 33%) at 2 days, but the difference was not significant at 1 month (54% versus 49%). Investigator-rated pain...
Seher Kocaoglu - One of the best experts on this subject based on the ideXlab platform.
-
evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome
American Journal of Physical Medicine & Rehabilitation, 2005Co-Authors: Figen Gokoglu, G Findikoglu, Z R Yorgancoglu, Muyesser Okumus, Esma Ceceli, Seher KocaogluAbstract:OBJECTIVE: The aim of this study was to compare the efficacy of local corticosteroid injection with iontophoresis of corticosteroids in the treatment of carpal tunnel syndrome. DESIGN: This study was a prospective, randomized, unblinded clinical trial with follow-up at 2 and 8 wks. Thirty patients (48 median nerves) with clinical and electrophysiologic evidence of carpal tunnel syndrome were included in the study. Patients were evaluated by use of clinical variables, a functional status scale, a symptom severity scale, and visual analog scale. A total of 48 median nerves were randomly assigned to one of two groups; group 1 received 40 mg of methylprednisolone acetate injected locally in the carpal tunnel, and group 2 received iontophoresis of Dexamethasone Sodium Phosphate. Clinical variables and scales were evaluated at regular intervals: at the beginning and at the end of therapy in the second and eighth week. RESULTS: Twenty-seven patients (90%) were women and three patients (10%) were men. The mean age of patients was 48.0 +/- 8.2 (range, 29-61) yrs. There was a statistically significant improvement in the clinical examination variables, visual analog scale, symptom severity scale, and functional status scale scores of the patients in both of the treatment groups posttreatment (at 2 and 8 wks) compared with baseline (P < 0.05). However, there was a statistically significant difference between the values of the two group. A significant difference in mean symptom severity scale, functional status scale, and visual analog scale scores was found in second week and eighth week in the injection group compared with iontophoresis. CONCLUSION: Our study comparing a standardized treatment protocol for incorporating local corticosteroid injection and iontophoresis of Dexamethasone Sodium Phosphate in carpal tunnel syndrome revealed success of both iontophoresis of Dexamethasone Sodium Phosphate and injection of corticosteroids, but symptom relief was greater at 2 and 8 wks with injection of corticosteroids.
Robert P. Nirschl - One of the best experts on this subject based on the ideXlab platform.
-
Iontophoretic Administration of Dexamethasone Sodium Phosphate for Acute Epicondylitis A Randomized, Double-Blinded, Placebo-Controlled Study
2016Co-Authors: Robert P. NirschlAbstract:Background: A better treatment modality is needed to control the pain of medial or lateral epicondylitis (tennis elbow). Hypothesis: Dermal iontophoretic administration of Dexamethasone Sodium Phosphate will be significantly more effective in controlling pain than a placebo in patients with medial or lateral elbow epicondylitis. Study Design: Randomized, double-blinded, placebo-controlled study. Methods: On six occasions, 1 to 3 days apart within 15 days, 199 patients with elbow epicondylitis received 40 mA-minutes of either active or placebo treatment. Results: Dexamethasone produced a significant 23-mm improvement on the 100-mm patient visual analog scale ratings
-
iontophoretic administration of Dexamethasone Sodium Phosphate for acute epicondylitis a randomized double blinded placebo controlled study
American Journal of Sports Medicine, 2003Co-Authors: Robert P. Nirschl, Dennis Rodin, Derek Ochiai, Craig MaartmannmoeAbstract:Background: A better treatment modality is needed to control the pain of medial or lateral epicondylitis (tennis elbow).Hypothesis: Dermal iontophoretic administration of Dexamethasone Sodium Phosphate will be significantly more effective in controlling pain than a placebo in patients with medial or lateral elbow epicondylitis.Study Design: Randomized, double-blinded, placebo-controlled study.Methods: On six occasions, 1 to 3 days apart within 15 days, 199 patients with elbow epicondylitis received 40 mA-minutes of either active or placebo treatment.Results: Dexamethasone produced a significant 23-mm improvement on the 100-mm patient visual analog scale ratings, compared with 14 mm for placebo at 2 days and 24 mm compared with 19 mm at 1 month. More patients treated with Dexamethasone than those treated with placebo scored moderate or better on the investigator's global improvement scale (52% versus 33%) at 2 days, but the difference was not significant at 1 month (54% versus 49%). Investigator-rated pain...
Mojtaba Malek - One of the best experts on this subject based on the ideXlab platform.
-
phonophoresis of Dexamethasone Sodium Phosphate may manage pain and symptoms of patients with carpal tunnel syndrome
The Clinical Journal of Pain, 2013Co-Authors: Amir Hoshang Bakhtiary, Elham Fatemi, Mitra Emami, Mojtaba MalekAbstract:Objectives:This study was designed to compare the efficacy of iontophoresis and phonophoresis of Dexamethasone Sodium Phosphate (Dex-P) treatment for mild to moderate carpal tunnel syndrome (CTS).Methods:Fifty-two hands in 34 consecutive patients with mild to moderate CTS confirmed by electromyograp
Figen Gokoglu - One of the best experts on this subject based on the ideXlab platform.
-
evaluation of iontophoresis and local corticosteroid injection in the treatment of carpal tunnel syndrome
American Journal of Physical Medicine & Rehabilitation, 2005Co-Authors: Figen Gokoglu, G Findikoglu, Z R Yorgancoglu, Muyesser Okumus, Esma Ceceli, Seher KocaogluAbstract:OBJECTIVE: The aim of this study was to compare the efficacy of local corticosteroid injection with iontophoresis of corticosteroids in the treatment of carpal tunnel syndrome. DESIGN: This study was a prospective, randomized, unblinded clinical trial with follow-up at 2 and 8 wks. Thirty patients (48 median nerves) with clinical and electrophysiologic evidence of carpal tunnel syndrome were included in the study. Patients were evaluated by use of clinical variables, a functional status scale, a symptom severity scale, and visual analog scale. A total of 48 median nerves were randomly assigned to one of two groups; group 1 received 40 mg of methylprednisolone acetate injected locally in the carpal tunnel, and group 2 received iontophoresis of Dexamethasone Sodium Phosphate. Clinical variables and scales were evaluated at regular intervals: at the beginning and at the end of therapy in the second and eighth week. RESULTS: Twenty-seven patients (90%) were women and three patients (10%) were men. The mean age of patients was 48.0 +/- 8.2 (range, 29-61) yrs. There was a statistically significant improvement in the clinical examination variables, visual analog scale, symptom severity scale, and functional status scale scores of the patients in both of the treatment groups posttreatment (at 2 and 8 wks) compared with baseline (P < 0.05). However, there was a statistically significant difference between the values of the two group. A significant difference in mean symptom severity scale, functional status scale, and visual analog scale scores was found in second week and eighth week in the injection group compared with iontophoresis. CONCLUSION: Our study comparing a standardized treatment protocol for incorporating local corticosteroid injection and iontophoresis of Dexamethasone Sodium Phosphate in carpal tunnel syndrome revealed success of both iontophoresis of Dexamethasone Sodium Phosphate and injection of corticosteroids, but symptom relief was greater at 2 and 8 wks with injection of corticosteroids.